Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Biomaterials. 2016 Feb 18;88:25–33. doi: 10.1016/j.biomaterials.2016.02.021

Fig. 2.

Fig. 2

(a) Schematic illustration of Dox-loaded pMNCs for IA drug delivery, (b) digital image of sample solutions (Dox-pMNCs, Dox-pMNCs with Lipiodol and Dox with Lipiodol) and (b) Release profiles of Dox from the samples (Dox-pMNCs, Dox-pMNCs with Lipiodol and Dox with Lipiodol). The profiles of Dox-pMNCs and Dox-pMNCs with Lipiodol showed relatively slow and sustained drug release over 100 hours (at 37 cC).